Stay updated on MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.

Latest updates to the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page
- Check5 days agoChange DetectedSitewide outage warning and the NCBI service delay notice were removed from the page, removing prominent system-status alerts from the study details view.SummaryDifference0.1%

- Check12 days agoChange DetectedA sitewide outage banner and a note about intermittent delays were added, and the revision tag was updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe revision label on the page was updated from v3.6.3 to v3.6.4, indicating a software release update for the page. The change is a backend version bump rather than content or data changes on the page.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now shows Revision: v3.6.3 as the current document version and no longer shows Revision: v3.6.1. This indicates an updated protocol/document is available for reference.SummaryDifference0.0%

- Check70 days agoChange DetectedRecruitment status updated to indicate enrollment is closed. New help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was adjusted.SummaryDifference0.3%

- Check78 days agoChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, indicating a minor update to the page's version history without altering displayed content.SummaryDifference0.0%

Stay in the know with updates to MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.